Neupulse strengthens their executive team

February 27, 2023

Neupulse is excited to announce that it has recruited 2 new key executives to their senior management team.

Paul Cable, Neupulse’s current Chief Operating Officer, has been promoted to Chief Executive Officer. Paul has been with the Company since inception, and has been instrumental in leading the Neupulse team to achieving its milestones to date. Paul has over 30 years of global management experience in the MedTech industry, and has a unique ability to steer cross-functional teams to success across the entire life cycle of developing medical devices and bringing them to market.

‘It is a privilege to lead Neupulse and work with such a talented, driven team to achieve our goal of becoming the first non-invasive, game-changing treatment option for individuals with Tourette’s Syndrome around the world.’

Paul Cable, Chief Executive Officer

Also joining Neupulse as its Chief Technology Officer is Doctor David Moser. David is a Chartered Engineer and Visiting Professor of Engineering at the University of Southampton, with a PhD in Biomedical Engineering and over 17 years of experience developing wearable assistive technologies and medical devices.

David was formerly Director of Research and Technology at Blatchford, where he led the development of some of the world’s most advanced, award-winning prosthetics, including the RAEng MacRobert Award in 2016, and the US Medical Device Excellence Award in 2017.

David holds over 25 patents and has published extensively in the areas of prosthetics, body interface technologies, robotics, physical rehabilitation, and digital health. As CTO, David will head up Neupulse’s Technology and New Product Development team.

Media contact:

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road

Privacy Notice       Cookies

Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Tourettes Friendly Organisation
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action.
Medilink Midlands Awards
Back to Top